Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have more insulin resistance and are more likely to have heart-related health issues, with insulin resistance being a bigger factor than β-cell problems.

Iron levels are linked to insulin resistance in men and postmenopausal women, but not in premenopausal women.

Hair loss is linked to insulin resistance in women, regardless of hormone levels.

Dobutamine does not mimic dopamine at therapeutic doses but may at very high concentrations; microfilaments, not microtubules, are important for wound healing in Xenopus embryos.

Managing emotional distress, obesity, insulin resistance, and high male hormones is crucial for improving well-being in women with PCOS.

Women with PCOS have higher hair cortisol levels, which are linked to worse metabolic and inflammatory conditions.

Hair loss may signal metabolic problems and increased risk of heart disease, suggesting people with hair loss should be checked for these issues.

A postmenopausal woman's high testosterone levels and symptoms improved after removing a tumor from her ovary.

Women with PCOS and polycystic ovaries have higher male hormone levels and more insulin resistance, especially if they are overweight.

The study concluded that the most common skin problems in women with PCOS are excess hair, acne, oily skin, hair loss, dark skin patches, and skin tags.

High Lipid Accumulation Product levels are linked to more hirsutism in women with Polycystic Ovary Syndrome.

Women with idiopathic hirsutism and PCOS have higher RBP4 levels, and PCOS is linked to greater insulin resistance; weight management may help both conditions.

Hirsutism in young girls can have causes other than PCOS, so diagnoses should be reassessed if treatments don't work.

Women with PCOS often have sleep problems, including sleep apnea, which are linked to obesity and depression.

Chromium picolinate was better tolerated than metformin for PCOS with fewer side effects.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Taking metformin with intense pulsed light therapy improves hair removal for women with PCOS.

Men with early hair loss may have higher health risks similar to women with PCOS.

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Manage vitiligo with treatments, address emotions, and use camouflage techniques.

PCOS is common among Chinese women of reproductive age and linked to serious metabolic and reproductive issues, especially in obese women.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.